180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.


Disclaimer: This content is for informational purposes only and is not intended as financial advice.

Investment Overview:

This analysis highlights a speculative investment opportunity based primarily on technical analysis and the stock's trading characteristics.

Shares Outstanding: 0.52 million
Short Interest: 8.14%

Key Technical Levels:

Resistance Levels: Watch for potential upward movements if the price breaks through the resistance levels at $2.30, $2.90, and $3.70. Consider taking partial profits at these points to lock in gains.

Trading Strategy:

Take Profit (TP): Aim for a target price of around $4.40 to secure profits.

Stop Loss (SL): Implement a stop loss strategy below $1.70 to minimize potential losses.

Chart Analysis: Refer to the accompanying chart for a visual representation of price actions and trends.

Trading Caution: This opportunity involves significant risk. It is essential to conduct your own research or consult with a professional advisor before engaging in trading activities.
ملاحظة
Hit 2.36 today
أغلقت الصفقة: تم الوصول لوقف الخسارة
ملاحظة
Booooom - took a while hit SL but it was the right smell at the end!
Technical IndicatorsTrend Analysis

إخلاء المسؤولية